Suppressed gastric mucosal TGF-β1 increases susceptibility to H. pylori-induced gastric inflammation and ulceration: A stupid host defense response

Gut and Liver

Volumn 4, Issue 1, 2010, Pages 43-53

  Jo, Yunjeong ^a   Han, Sang Uk ^b   Kim, Yoon Jae ^a   Kim, Ju Hyeon ^a   Kim, Shin Tae ^a   Kim, Seong Jin ^a   Hahm, Ki Baik ^a  

^a Gachon University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Helicobacter pylori; Host defense; Inflammation; TGF ; Ulcer

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; BACTERIUM ADHERENCE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; FEMALE; GASTRITIS; GENE EXPRESSION REGULATION; HELICOBACTER INFECTION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MUCOSA CELL; PEPTIC ULCER; STOMACH MUCOSA; STOMACH ULCER;

EID: 77949785289     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2010.4.1.43     Document Type: Article

References (39)

1. Marshall BJ, Warren JR. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983;1: 1273-1275.
2. Go MF. What are the host factors that place an individual at risk for Helicobacter pylori-associated disease? Gastroenterology 1997;113:S15-S20.
3. Mimuro H, Suzuki T, Nagai S, et al. Helicobacter pylori dampens gut epithelial self-renewal by inhibiting apoptosis, a bacterial strategy to enhance colonization of the stomach. Cell Host Microbe 2007;2:250-263.
4. Mobley HL. Helicobacter pylori factors associated with disease development. Gastroenterology 1997;113:S21-S28.
5. Jiang Q, Hiratsuka K, Taylor DE. Variability of gene order in different Helicobacter pylori strains contributes to genome diversity. Mol Microbiol 1996;20:833-842.
6. Replogle ML, Glaser SL, Hiatt RA, Parsonnet J. Biologic sex as a risk factor for Helicobacter pylori infection in healthy young adults. Am J Epidemiol 1995;142:856-863.
7. Azuma T, Konishi J, Tanaka Y, et al. Contribution of HLA-DQA gene to host's response against Helicobacter pylori. Lancet 1994;343:542-543.
8. Niv Y, Fraser G, Delpre G, et al. Helicobacter pylori infection and blood groups. Am J Gastroenterol 1996;91:101-104.
9. Calam J. The somatostatin-gastrin link of Helicobacter pylori infection. Ann Med 1995;27:569-573.
10. Roberts AB, Sporn MB. Peptide growth factors and their receptors. In: Robert AB, Sporn MB, eds. Handbook of experimental pharmacology. 1st ed. Heidelberg: Springer-Verlag, 1990:419-472.
11. Massague J, Attisano L, Wrana JL. The TGF-beta family and its composite receptors. Trends Cell Biol 1994;4:172-178.
12. Kim DH, Kim SJ. Transforming growth factor-beta receptors: role in physiology and disease. J Biomed Sci 1996; 3:143-158.
13. Roberts AB. Transforming growth factor-beta: activity and efficacy in animal models of wound healing. Wound Repair Regen 1995;3:408-418.
14. Tsunawaki S, Sporn M, Ding A, Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature 1988;334:260-262.
15. Kulkarni AB, Huh CG, Becker D, et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A 1993;90:770-774.
16. Boivin GP, O'Toole BA, Orsmby IE, et al. Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice. Am J Pathol 1995;146:276-288.
17. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981;29:577-580.
18. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-1181.
19. Park K, Kim SJ, Bang YJ, et al. Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta. Proc Natl Acad Sci U S A 1994;91:8772-8776.
20. Talamini G, Zamboni G, Cavallini G. Antral mucosal Helicobacter pylori infection density as a risk factor of duodenal ulcer. Digestion 1997;58:211-217.
21. Davies GR, Banatvala N, Collins CE, et al. Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol 1994;29:419-424.
22. Sakagami T, Dixon M, O'Rourke J, et al. Atrophic gastric changes in both Helicobacter felis and Helicobacter pylori infected mice are host dependent and separate from antral gastritis. Gut 1996;39:639-648.
23. Kirchner T, Steininger H, Faller G. Immunopathology of Helicobacter pylori gastritis. Digestion 1997;58 Suppl 1:14-16.
24. Hahm KB, Park IS, Kim YS, et al. Role of rebamipide on induction of heat-shock proteins and protection against reactive oxygen metabolite-mediated cell damage in cultured gastric mucosal cells. Free Radic Biol Med 1997;22:711-716.
25. Stromberg E, Edebo A, Svennerholm AM, Lindholm C. Decreased epithelial cytokine responses in the duodenal mucosa of Helicobacter pylori-infected duodenal ulcer patients. Clin Diagn Lab Immunol 2003;10:116-124.
26. Hahm KB, Lee KJ, Choi SY, et al. Possibility of chemoprevention by the eradication of Helicobacter pylori: oxidative DNA damage and apoptosis in H. pylori infection. Am J Gastroenterol 1997;92:1853-1857.
27. Wilson KT, Ramanujam KS, Mobley HL, Musselman RF, James SP, Meltzer SJ. Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line. Gastroenterology 1996;111:1524-1533.
28. Fujiwara Y, Wyle F, Arakawa T, et al. Helicobacter pylori culture supernatant inhibits binding and proliferative response of human gastric cells to epidermal growth factor: implications for H. pylori interference with ulcer healing? Digestion 1997;58:299-303.
29. NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994;272:65-69.
30. Ashcroft GS, Dodsworth J, van Boxtel E, et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 1997;3:1209-1215.
31. Gold LI, Sung JJ, Siebert JW, Longaker MT. Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair. Am J Pathol 1997;150:209-222.
32. Coerper S, Sigloch E, Cox D, Starlinger M, Koveker G, Becker HD. Recombinant human transforming growth factor beta 3 accelerates gastric ulcer healing in rats. Scand J Gastroenterol 1997;32:985-990.
33. Graham DY, Go MF. Helicobacter pylori: current status. Gastroenterology 1993;105:279-282.
34. Hentschel E, Brandstatter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-312.
35. Romano M, Ricci V, Di Popolo A, et al. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells. J Clin Invest 1998;101:1604-1613.
36. Boivin GP, Molina JR, Ormsby I, Stemmermann G, Doetschman T. Gastric lesions in transforming growth factor beta-1 heterozygous mice. Lab Invest 1996;74:513-518.
37. Mezey E, Palkovits M. Localization of targets for anti-ulcer drugs in cells of the immune system. Science 1992;258:1662-1665.
38. Appelmelk BJ, Simoons-Smit I, Negrini R, et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun 1996;64:2031-2040.
39. Kuipers EJ, Klinkenberg-Knol EC, Vandenbroucke-Grauls CM, Appelmelk BJ, Schenk BE, Meuwissen SG. Role of Helicobacter pylori in the pathogenesis of atrophic gastritis. Scand J Gastroenterol Suppl 1997;223:28-34.